Truist Financial Corp Reduces Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Truist Financial Corp cut its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 2.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 45,650 shares of the company’s stock after selling 1,077 shares during the period. Truist Financial Corp’s holdings in Acadia Healthcare were worth $1,810,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. State Street Corp increased its holdings in Acadia Healthcare by 3.5% in the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock valued at $178,811,000 after buying an additional 95,613 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of Acadia Healthcare by 17.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after purchasing an additional 454,044 shares in the last quarter. SG Americas Securities LLC increased its stake in shares of Acadia Healthcare by 713.3% during the 4th quarter. SG Americas Securities LLC now owns 110,866 shares of the company’s stock worth $4,396,000 after purchasing an additional 97,235 shares in the last quarter. Beach Point Capital Management LP purchased a new position in shares of Acadia Healthcare during the 4th quarter worth approximately $14,097,000. Finally, LMR Partners LLP purchased a new position in shares of Acadia Healthcare during the 3rd quarter worth approximately $1,616,000.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on ACHC. Royal Bank of Canada reissued an “outperform” rating and set a $64.00 price objective on shares of Acadia Healthcare in a research note on Friday, January 10th. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. TD Cowen dropped their price objective on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and raised their target price for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. Finally, KeyCorp upgraded shares of Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 target price on the stock in a research report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $70.22.

Acadia Healthcare Stock Down 3.2 %

Shares of ACHC opened at $41.00 on Thursday. The firm has a market cap of $3.81 billion, a PE ratio of 13.44, a price-to-earnings-growth ratio of 1.46 and a beta of 1.30. The company’s fifty day moving average is $42.22 and its two-hundred day moving average is $52.30. Acadia Healthcare Company, Inc. has a fifty-two week low of $36.50 and a fifty-two week high of $87.77. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.